Teleflex FY 2025 GAAP revenue rises 17.2% to USD 1.99 billion

Reuters02-26 19:31
Teleflex FY 2025 GAAP revenue rises 17.2% to USD 1.99 billion

Teleflex reported FY 2025 GAAP revenue from continuing operations of USD 1.99 billion, up 17.2%, with GAAP diluted EPS from continuing operations of USD 1.31. Adjusted revenue from continuing operations was USD 1.98 billion, up 16.3%, and adjusted diluted EPS from continuing operations was USD 6.98. For FY 2026, Teleflex guided to GAAP revenue from continuing operations of USD 2.28 billion to USD 2.30 billion, implying 14.4% to 15.4% growth, and GAAP EPS from continuing operations of USD 2.90 to USD 3.20; adjusted diluted EPS is expected at USD 6.25 to USD 6.55. The company said it is progressing strategic divestitures (Acute Care, Interventional Urology, and OEM, classified as discontinued operations in Q4 2025) that it expects to close in H2 2026, and highlighted an initial restructuring plan intended to mitigate stranded costs, targeting annual pre-tax savings of USD 48 million to USD 52 million once fully implemented, with stranded costs estimated at USD 90 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teleflex Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260226570435) on February 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment